References
- Komaroff AL, Buchwald DS. Chronic Fatigue Syndrome: An Update. Annu Rev Med 1998;49:1–13.
- Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The Impact of Fa-tigue on Patients with Multiple Sclerosis. Can J Neurol Sci 1994;21:9–14.
- Murray TJ. Amantadine Therapy for Fatigue in Multiple Sclerosis. Can J Neurol Sci 1985;12:251–254.
- Karlsen K, Larsen JP, Tandberg E, Jorgensen K. Fatigue in Patients with Par-kinson's Disease. Mov Disord 1999;14:237–241.
- Lin JS, Roussel B, Akaoka H, Fort P, DebiIly G, Jouvet M. Role of Catecholamines in the Modafinil and Amphetamine Induced Wakefulness, a Comparative Pharmaco-logical Study in the Cat. Brain Res 1992;591:319–326.
- Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K. Modafinil: An Antinarcoleptic Drug with a Different Neurochemical Profile to D-Am-phetamine and Dopamine Uptake Blockers. Biol Psychiatry 1997;42:1181–1183.
- Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic Arousal Re-gions Are Activated During Modafinil-Induced Wakefulness. J Neurosci 2000;in press.
- U.S. Modafinil in Narcolepsy Multicenter Study Group. Randomized Trial of Modafinil as a Treatment for the Excessive Daytime Somnolence of Narcolepsy. Neu-rology 2000;54:1166–1175.
- U.S. Modafinil in Narcolepsy Multicenter Study Group. Randomized Trial of Modafinil for the Treatment of Pathological Somnolence in Narcolepsy. Ann Neurol 1998;43:88–97.
- Arnulf I, Homeyer P, Garma L, Whitelaw WA, Derenne J-P. Modafinil in Ob-structive Sleep Apnea-Hypopnea Syndrome: A Pilot Study in 6 Patients. Respiration 1997;64: 159–161.
- Bastuji H, Jouvet M. Successful Treatment of Idiopathic Hypersomnia and Narcolepsy with Modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988;12: 695–700.
- Batejat DM, Lagarde DP. Naps and Modafinil as Countermeasures for the Ef-fects of Sleep Deprivation on Cognitive Performance. Aviat Space Environ Med 1999;70:493–498.
- Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, d-Amphetamine and Placebo During 64 Hours of Sustained Mental Work. II. Effects on Two Nights of Re-covery Sleep. J Sleep Res 1995;4:229–241.
- Rammohan KW, Rosenberg JH, Pollak CP, Lynn DJ, Blumenfeld A, Nagaraja HN. PROVIGIL (Modafinil): Efficacy for the Treatment of Fatigue in Patients with Multiple Sclerosis. Neurology 2000;54:A24.
- Terzoudi M, Gavrielidou P, Heilakos G, Visviki K, Karageorgiou CE. Fatigue in Multiple Sclerosis. Evaluation and a New Pharmacological Approach. Neurology 2000;54:A61–A62.
- Menza MA, Kaufman KR, Castellanos A. Modafinil Augmentation of Antide-pressant Treatment in Depression. J Clin Psychiatry 2000;61:378–381.